does semaglutide cause kidney damage in Diabetic Disease: Integrating Clinical Evidence with Mechanistic Insights Ozempic and GLP-1 Drugs: Risk

This is consistent with the FDA-approved label

A comparison of efficacy and safety of vildagliptin and gliclazide in combination with metformin in patients with Type 2 diabetes inadequately controlled with metformin alone: a 52-week, randomized study

Mark Turner, HSE assistant national director, said there was a strong suggestion that off-label prescribing to obesity patients was further challenging supplies of the drug, which is taken by regular injection

What the Clinical Evidence Shows About GLP-1 and Thyroid Nodules The FDA issued a class warning for GLP-1 agonists based on animal studies showing medullary thyroid carcinoma (MTC) risk at supratherapeutic doses

[DOI] [PMC free article] [PubMed] [Google Scholar] 53

So maybe investing in prevention isnt worth as much to you as it is to Medicare, he says